Ponesimod, a selective sphingosine 1-phosphate (S1P₁) receptor modulator for autoimmune diseases: review of clinical pharmacokinetics and drug disposition

Medicine & Life Sciences

• ponesimod 100%
• Sphingosine 1 Phosphate Receptor Modulators 86%
• Sphingosine-1-Phosphate Receptors 69%
• Autoimmune Diseases 43%
• Pharmacokinetics 37%
• Pharmaceutical Preparations 20%
• ACT-204426 15%
• Psoriasis 12%
• Multiple Sclerosis 10%
• Lymphocytes 8%
• Safety 7%
• Half-Life 5%
• Population 4%
• Eating 4%
• Heart Rate 4%
• Body Weight 4%
• Liver 3%
• Therapeutics 3%

Chemical Compounds

• Receptor Modulator 78%
• Sphingosine 1-Phosphate 78%
• Pharmacokinetics 37%
• Drug 26%
• Safety 21%
• Elimination Half-Life 18%
• Marker 10%
• Dose 9%
• Food 8%
• Time 4%